Skip to main content
Quest Diagnostics Home

Moving New Diagnostics into the Clinic in the 21st Century

Date: Monday, Dec 9, 2019

Description: Together with One Brave Idea™ we’ll explore the reasons traditional biomarkers for coronary heart disease (CHD) are insufficient, and why we must work across boundaries, old assumptions, and disciplines to reimagine the future in order to prevent, detect, and treat CHD. Hosted by: One Brave Idea™ and Quest Diagnostics®

Our company

Locations Careers Investors Specialty labs Newsroom
Site map   •   Privacy Notices   •   Terms   •   Contact us   •   Language assistance / non-discrimination   •   Asistencia de idiomas / Aviso de no discriminación   •   語言協助 / 不歧視通知   •   Privacy Shield   •   Accessibility   •   Your Privacy Choices

Quest, Quest Diagnostics, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2022 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.